改良Appleby手术与动脉鞘剥除技术治疗局部进展期胰体尾癌的比较
该回顾性研究纳入58例交界可切除或局部进展期动脉受累胰体尾癌患者,比较改良Appleby手术(DP-CAR,31例)与动脉鞘剥除技术(SDT,27例)的围术期与随访结局。结果显示DP-CAR组总体并发症、B/C级胰瘘、联合器官切除比例更高,手术时间与术后住院时间更长;两组R0+R1(<1 mm)切除率、淋巴结阳性率及无病生存与总体生存均无显著差异。
要点
- DP-CAR组总体并发症71.0%高于SDT组29.6%,以B/C级胰瘘更突出。
- 两组R0+R1(<1 mm)切除率、无病生存与总体生存差异均无统计学意义。
- 对动脉受累胰体尾癌,两种术式均可行,SDT围术期负担更轻。
核心结论
- 对交界可切除或局部进展期动脉受累胰体尾癌,DP-CAR与SDT均安全可行。
- SDT较DP-CAR可降低总体并发症发生率并缩短住院时间,但长期生存无差异。
研究设计与样本
- 单中心回顾性研究,纳入2013年9月至2019年5月南京医科大学第一附属医院胰腺中心连续58例患者。
- 男性33例、女性25例,年龄62(9)岁(范围43~79岁);DP-CAR组31例,SDT组27例。
- 定量资料用Wilcoxon检验,分类变量用χ²检验或Fisher确切概率法,生存用Kaplan-Meier法与Log-rank检验。
主要发现
- DP-CAR组手术时间310(123)min长于SDT组254(137)min(Z=2.277,P=0.023)。
- DP-CAR组联合器官切除41.9%(13/31)高于SDT组14.8%(4/27)(χ²=5.123,P=0.041)。
- DP-CAR组术后住院时间15(10)d长于SDT组11(5)d(Z=2.292,P=0.022)。
- DP-CAR组总体并发症71.0%(22/31)高于SDT组29.6%(8/27)(χ²=9.876,P=0.003),B/C级胰瘘61.3%(19/31)高于29.6%(8/27)(χ²=5.814,P=0.020)。
- DP-CAR组肿瘤最大径4.9(1.5)cm大于SDT组4.0(1.2)cm(Z=2.343,P=0.019)。
关键数值与推荐
- SDT组术前3个月体重明显减轻发生率48.1%(13/27)高于DP-CAR组19.4%(6/31)(χ²=5.431,P=0.020)。
- 两组R0+R1(<1 mm)切除率84.0%(21/25)比90.0%(18/20),P=0.678。
- 两组淋巴结阳性率12.0(23.0)%比9.0(18.0)%,Z=1.238,P=0.216。
- 两组中位无病生存11.7个月比11.4个月(Z=0.019,P=0.892),中位总体生存16.3个月比13.7个月(Z=0.172,P=0.679)。
临床怎么用
- 对交界可切除或局部进展期动脉受累胰体尾癌,可在DP-CAR与SDT间个体化选择。
- 若更关注降低围术期并发症与缩短住院,SDT可能更有利,但不应期待长期生存获益。
局限性
- 单中心回顾性研究,样本量58例,两组基线在体重减轻与肿瘤大小上存在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To compare the outcomes of modified Appleby procedure and sub-adventitial divestment technique for locally advanced or borderline resectable pancreatic body cancer. Methods: A total of consecutive 58 patients(33 males and 25 females) who were diagnosed as locally advanced or borderline resectable pancreatic body cancer and underwent distal pancreatectomy at Pancreas Center, First Affiliated Hospital of Nanjing Medical University between September 2013 and May 2019 were retrospectively reviewed. The age(M(IQR)) was 62(9)years(range: 43 to 79 years). Thirty-one patients underwent distal pancreatectomy with celiac axis resection (DP-CAR) and 27 patients underwent distal pancreatectomy with sub-adventitial divestment technique(SDT). Perioperative parameters and follow-up data of these patients were analyzed. Quantitative data were compared with Wilcoxon test while categorical variables were compared with χ2 test or Fisher's exact test. Survival results were estimated by the Kaplan-Meier survival method with a Log-rank test. Results: There were no differences in age,gender,body mass index,abdominal symptoms,comorbidity or preoperative serum CA19-9 between two groups(all P>0.05). Obvious preoperative weight loss was more common in the group of SDT(48.1%(13/27) vs. 19.4%(6/31),χ²=5.431,P=0.020). Longer operative time(310(123) minutes vs. 254(137)minutes, Z=2.277,P=0.023),higher rate of combined organ resection(41.9%(13/31) vs. 14.8%(4/27),χ²=5.123,P=0.041) and longer postoperative hospital stay(15(10) days vs. 11(5)days,Z=2.292,P=0.022) were observed in the group of DP-CAR. Moreover,rate of overall morbidities was also higher (71.0%(22/31) vs. 29.6%(8/27),χ2=9.876,P=0.003),implicated by clinically relevant postoperative pancreatic fistula(61.3%(19/31) vs. 29.6%(8/27),χ2=5.814,P=0.020) in the DP-CAR group. Tumor size of the DP-CAR group was bigger(4.9(1.5)cm vs. 4.0(1.2)cm,Z=2.343,P=0.019) but no difference was seen between the DP-CAR group and SDT group in R0+R1(<1 mm) resection rate (84.0%(21/25) vs. 90.0%(18/20),P=0.678) and LNR(12.0(23.0)% vs. 9.0(18.0)%,Z=1.238,P=0.216),as well as median disease free survival(11.7 months vs. 11.4 months,Z=0.019,P=0.892) and median overall survival(16.3 months vs. 13.7 months,Z=0.172,P=0.679). Conclusions: Both DP-CAR and distal pancreatectomy with SDT are relatively safe and feasible for locally advanced or borderline resectable pancreatic body cancer. Compared with arterial resection,SDT may contribute to lower rates of postoperative complications and shorter duration of hospitalization,but no significant benefit is seen in long-term survival. 目的: 比较改良Appleby手术和动脉鞘剥除技术治疗动脉受累胰体尾癌的临床效果。 方法: 回顾性分析2013年9月至2019年5月南京医科大学第一附属医院胰腺中心收治的58例交界可切除或局部进展期动脉受累胰体尾癌患者资料。男性33例,女性25例;年龄[M(IQR)]62(9)岁(范围:43~79岁)。其中31例行改良Appleby手术(DP-CAR组),27例行动脉鞘剥除的胰体尾癌根治术(SDT组)。收集两组患者术前、术中及术后资料。定量资料的组间比较采用Wilcoxon 秩和检验,分类变量的组间比较采用χ²检验或 Fisher 确切概率法,通过Kaplan-Meier法比较两组患者的生存情况。 结果: 两组患者在年龄、体重指数、性别比例、腹部症状、合并症及术前血清CA19-9水平等的差异均无统计学意义(P值均>0.05)。SDT组术前3个月体重明显减轻的发生率更高[48.1%(13/27)比19.4%(6/31),χ²=5.431,P=0.020];DP-CAR组手术时间更长[310(123)min比254(137)min,Z=2.277,P=0.023]、联合器官切除比例更多[41.9%(13/31)比14.8%(4/27),χ²=5.123,P=0.041]、术后住院时间更长[15(10)d比11(5)d,Z=2.292,P=0.022]、总体并发症发生率更高[71.0%(22/31)比29.6%(8/27),χ²=9.876,P=0.003],主要表现在B、C级胰瘘的发生率更高[61.3%(19/31)比29.6%(8/27),χ²=5.814,P=0.020],其他主要并发症的发生率差异无统计学意义(P<0.05)。DP-CAR组肿瘤最大径更长[4.9(1.5)cm比4.0(1.2)cm,Z=2.343,P=0.019],DP-CAR组与SDT组的R0+R1(<1 mm)切除率[84.0%(21/25)比90.0%(18/20),P=0.678]、淋巴结阳性率[12.0(23.0)%比9.0(18.0)%,Z=1.238,P=0.216]、中位无病生存时间(11.7个月比11.4个月,Z=0.019,P=0.892)及中位总体生存时间(16.3个月比13.7个月,Z=0.172,P=0.679)的差异均无统计学意义。 结论: 对交界可切除或局部进展期动脉受累胰体尾癌患者行改良Appleby手术或联合动脉鞘剥除胰体尾癌根治术是可行的。动脉鞘剥除技术较改良Appleby手术可降低手术总体并发症的发生率、缩短住院时间,但两者长期生存未见差异。.
引用
- Huang XM, Yin J, Lu ZP, et al. [Comparison of distal pancreatectomy with celiac axis resection and sub-adventitial divestment technique for locally advanced or borderline resectable pancreatic body cancer]. Zhonghua Wai Ke Za Zhi. 2022. PMID: 35359085. doi:10.3760/cma.j.cn112139-20210824-00390
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。